SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-019960
Filing Date
2024-05-15
Accepted
2024-05-15 16:52:16
Documents
62
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1153127
2 ex31-1.htm EX-31.1 12022
3 ex31-2.htm EX-31.2 11697
4 ex32-1.htm EX-32.1 7849
5 ex32-2.htm EX-32.2 7556
6 form10-q_001.jpg GRAPHIC 4616
  Complete submission text file 0001493152-24-019960.txt   6224218

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE mgrx-20240331.xsd EX-101.SCH 38911
8 XBRL CALCULATION FILE mgrx-20240331_cal.xml EX-101.CAL 48150
9 XBRL DEFINITION FILE mgrx-20240331_def.xml EX-101.DEF 228149
10 XBRL LABEL FILE mgrx-20240331_lab.xml EX-101.LAB 397758
11 XBRL PRESENTATION FILE mgrx-20240331_pre.xml EX-101.PRE 322684
66 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 764556
Mailing Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248
Business Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248 (833) 626-4679
MANGOCEUTICALS, INC. (Filer) CIK: 0001938046 (see all company filings)

IRS No.: 873841292 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41615 | Film No.: 24952171
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 03 Life Sciences)